Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53

被引:329
作者
Zhang, YP
Xiong, Y [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/S1097-2765(00)80351-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian ARF-INK4a locus uniquely encodes two cell cycle inhibitors by using separate promoters and alternative reading frames, p16(INK4a) maintains the retinoblastoma protein in its growth suppressive state while ARF stabilizes p53. We report that human ARF protein predominantly localizes to the nucleolus via a sequence within the exon 2-encoded C-terminal domain and is induced to leave the nucleolus by MDM2. ARF forms nuclear bodies with MDM2 and p53 and blocks p53 and MDM2 nuclear export. Tumor-associated mutations in ARF exon 2 disrupt ARF's nucleolus localization and reduce ARF's ability to block p53 nuclear export and to stabilize p53. Our results suggest an ARF-regulated MDM2-dependent p53 stabilization and link the human tumor-associated mutations in ARF with a functional alteration.
引用
收藏
页码:579 / 591
页数:13
相关论文
共 33 条
  • [1] The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
    Alcalay, M
    Tomassoni, L
    Colombo, E
    Stoldt, S
    Grignani, F
    Fagioli, M
    Szekely, L
    Helin, K
    Pelicci, PG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) : 1084 - 1093
  • [2] p14ARF links the tumour suppressors RB and p53
    Bates, S
    Phillips, AC
    Clark, PA
    Stott, F
    Peters, G
    Ludwig, RL
    Vousden, KH
    [J]. NATURE, 1998, 395 (6698) : 124 - 125
  • [3] E1A signaling to p53 involves the p19ARF tumor suppressor
    de Stanchina, E
    McCurrach, ME
    Zindy, F
    Shieh, SY
    Ferbeyre, G
    Samuelson, AV
    Prives, C
    Roussel, MF
    Sherr, CJ
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2434 - 2442
  • [4] A NOVEL MACROMOLECULAR STRUCTURE IS A TARGET OF THE PROMYELOCYTE-RETINOIC ACID RECEPTOR ONCOPROTEIN
    DYCK, JA
    MAUL, GG
    MILLER, WH
    CHEN, JD
    KAKIZUKA, A
    EVANS, RM
    [J]. CELL, 1994, 76 (02) : 333 - 343
  • [5] The CDKN2A (p16) gene and human cancer
    Foulkes, WD
    Flanders, TY
    Pollock, PM
    Hayward, NK
    [J]. MOLECULAR MEDICINE, 1997, 3 (01) : 5 - 20
  • [6] Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
    Freedman, DA
    Levine, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7288 - 7293
  • [7] p300/MDM2 complexes participate in MDM2-mediated p53 degradation
    Grossman, SR
    Perez, M
    Kung, AL
    Joseph, M
    Mansur, C
    Xiao, ZX
    Kumar, S
    Howley, PM
    Livingston, DM
    [J]. MOLECULAR CELL, 1998, 2 (04) : 405 - 415
  • [8] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    [J]. NATURE, 1997, 387 (6630) : 296 - 299
  • [9] RB regulates the stability and the apoptotic function of p53 via MDM2
    Hsieh, JK
    Chan, FSG
    O'Connor, DJ
    Mittnacht, S
    Zhong, S
    Lu, X
    [J]. MOLECULAR CELL, 1999, 3 (02) : 181 - 193
  • [10] A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES
    KAMB, A
    GRUIS, NA
    WEAVERFELDHAUS, J
    LIU, QY
    HARSHMAN, K
    TAVTIGIAN, SV
    STOCKERT, E
    DAY, RS
    JOHNSON, BE
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 264 (5157) : 436 - 440